Spectrum Pharmaceuticals Defeats Claims by CTI Over Joint Venture

Secured dismissal for Spectrum Pharmaceuticals against claims asserted by CTI arising out of a joint venture agreement. Spectrum asserted cross-claims against CTI arising out of the same joint venture. After a full hearing, the arbitrator denied CTI all relief on its complaint, and granted Spectrum all relief requested.*

*prior firm experience